Skip to content

Achilles Tendinopathy; the Effect of Shockwave Treatment

Comparison of Two Treatment Methods for Achilles Tendon Pain With a Focus on Pain, Function, Vascular Ingrowth, Immune Cell Response, and Cell Composition

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07685509
Enrollment
200
Registered
2026-07-06
Start date
2026-09-01
Completion date
2031-12-31
Last updated
2026-07-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Achilles Tendinopathy (AT), Achilles Tendon, Achilles Tendon Pain

Keywords

Achilles Tendinopathy, Shockwave, Insertional Achilles Tendinopathy, Exercise, Heel-rise

Brief summary

BACKGROUND Achilles tendinopathy-pain in the Achilles tendon-is a common and often long-lasting condition that limits physical activity and performance, and also affects work capacity and quality of life. The pain is localized either to the mid- portion of the tendon or at its insertion into the calcaneus. Although individually tailored exercise is the first-line treatment, symptoms persist in many patients, highlighting the need for adjunctive therapies. AIM This interdisciplinary and innovative research project aims to evaluate the effect of shockwave therapy in Achilles tendinopathy, both in cases where the pain is located in the mid-portion of the tendon and where it is situated at the tendon's insertion. In addition to assessing effects on pain and function, the study will examine the impact on calcifications, neovascularization (evaluated via Doppler ultrasound), and-uniquely-systemic immunological effects, with a focus on NK cells in the blood, an area that remains largely unexplored. METHOD This is a randomized controlled trial (RCT) with four arms, including 200 patients divided into two groups based on pain location. Half of the participants will receive adjunctive shockwave therapy in six sessions, in addition to exercise following the protocol by Silbernagel et al. The primary outcome measure is self-reported pain assessed using the Numeric Rating Scale (NRS) 0-10 at 12 months. Secondary outcomes include function, assessed through patient-reported outcomes (Victorian Institute of Sport Assessment-Achilles Swedish version, VISA-AS), calf muscle strength and endurance, and jumping ability using a validated test battery. Neovascularization and tendon cross-sectional area will be evaluated using ultrasound/Doppler. In a sub-cohort, immune cell composition in blood will be analyzed using flow cytometry before and after treatment. For patients undergoing surgery, tissue samples will also be collected for cellular composition analysis. SIGNIFICANCE This project has the potential to improve treatment strategies, reduce the need for surgery, and generate entirely new knowledge about the relationship between local tissue pathology and systemic immune responses.

Detailed description

Pain in the Achilles tendon, Achilles tendinopathy, is a common musculoskeletal condition affecting adults of all ages. The condition is characterized by localized pain and swelling in the Achilles tendon, particularly during tendon loading, functional limitations, and, in chronic cases, pathological neovascularization. Achilles tendinopathy is considered a typical overuse injury, and the diagnosis is made clinically. The incidence is reported to be 2/1000 per year, which would mean that approximately 1,400 individuals are affected each year in the Gothenburg area alone. A recent study from the United Kingdom has also shown that the typical patient is not physically active-as many clinical guidelines are designed for-but rather between 50 and 60 years old, has a high BMI, and often presents with comorbidities such as hypertension and diabetes. This highlights the need to review current clinical guidelines and evaluate the evidence for alternative treatments. The pain is usually load-related and located either in the midportion of the Achilles tendon or at its insertion on the calcaneus. The condition is often long-lasting despite adequate treatment, and in addition to limiting physical activity, it can also affect work ability and quality of life. Non-operative treatment with heel-raise exercises and load management-appropriately dosed exercise-is the first-line standard, although long-standing or treatment-resistant cases may require adjunct therapies. Among these, extracorporeal shockwave therapy (ESWT), administered either radially (rESWT) or focally (fESWT), has emerged as a promising intervention in several studies, although it has been questioned in others. Shockwave therapy targets both pain relief and restoration of function, but its effects on pain, function, tendon morphology, and immune cell levels remain largely unexplored. Recent systematic reviews have emphasized the need for higher-quality studies to determine whether adding shockwave therapy is beneficial for patients with Achilles tendinopathy. Evidence remains limited regarding whether shockwave therapy provides comparable pain relief for midportion versus insertional pain. Furthermore, it is unclear whether shockwave therapy must be combined with heel-raise exercises and load management or whether it can function as a standalone treatment. Doppler ultrasound is commonly used to quantify neovascularization in the tendon. Some studies have shown that shockwave therapy induces transient increases in neovascularization that coincide with clinical improvement, while others have found no effect on neovascularization. Tendon thickness and the effect of shockwave therapy on intratendinous calcifications have also been investigated, but no consensus has been reached. Much of this research area remains unexplored due to the small number of studies and limited sample sizes. Despite a growing evidence base suggesting that appropriately dosed exercise combined with shockwave therapy may be beneficial for tendon injuries, several areas remain under-investigated. Notably, no publications have been found on whether the micro-injuries potentially induced by shockwave therapy may cause systemic effects and thereby alter immune cell levels. Unpublished data from our research group have shown that early loading of a ruptured Achilles tendon increases circulating NK-cell levels, but whether this also applies to a painful tendon with potential tendinosis changes is unknown. The aim of this project is to evaluate two different treatment methods for patients with Achilles tendinopathy-appropriately dosed exercise alone or appropriately dosed exercise combined with shockwave therapy-with a focus on: Pain and muscle function Neovascularization and calcifications in the tendon Systemic changes in immune cell composition in the blood, with a focus on NK cells and CD8+ T cells Hypotheses Appropriately dosed exercise combined with shockwave therapy leads to reduced pain and improved function compared with appropriately dosed exercise alone. Appropriately dosed exercise combined with shockwave therapy reduces neovascularization and calcifications in the tendon. Appropriately dosed exercise combined with shockwave therapy induces micro-injuries in the tendon that generate a systemic immune response (higher levels of NK cells and CD8+ T cells). Appropriately dosed exercise combined with shockwave therapy has similar effects regardless of whether the pain is located in the midportion of the Achilles tendon or at its insertion. Significance This project has the potential to improve the treatment of Achilles tendinopathy by identifying which patients benefit from shockwave therapy and by increasing the understanding of the biological effects of different treatment methods. The results may contribute to more individualized treatment and reduce the need for surgical interventions.

Interventions

DEVICEindividually tailored exercises and Radial Shockwave

Shockwave: 5-6 treatments with radial shockwave, 10 bar, 2000-4000 pulses as an additional treatment to individually tailored exercises.

OTHERIndividually tailored exercises

Individually tailored exercises

Sponsors

Vastra Gotaland Region
Lead SponsorOTHER_GOV
Göteborg University
CollaboratorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Women and men over 18 years of age who seek care for load-related pain in the midportion of the Achilles tendon or at the Achilles tendon insertion at a Physiotherapy Clinic in Primary Care, at the Physiotherapy Department at Sahlgrenska University Hospital/Mölndal, or at the Orthopedic Department at Sahlgrenska University Hospital/Mölndal. * Symptoms must have been present for one month or longer. * Symptoms may be present in one or both Achilles tendons.

Exclusion criteria

* Unwillingness to receive shockwave therapy. * Previous shockwave therapy for Achilles tendon pain within the past year. * Neurological disease, significant cardiac conditions, increased bleeding tendency, treatment with anticoagulant medication, pregnancy, or presence of a tumor in the foot. * Corticosteroid injection in the foot within the past six months. * Reduced sensation, acute inflammation, or any wound around the heel. * Inability to understand or speak Swedish.

Design outcomes

Primary

MeasureTime frameDescription
Change in self-reported pain from baseline to 12 months after treatment startAt baseline and after 12 months after enrollmentZero is equivalent to no pain and 10 indicates the worst possible pain.

Secondary

MeasureTime frameDescription
Change in self-reported pain 3 and 6 months after treatment startAt baseline and after 3 and 6 months after enrollmentZero is equivalent to no pain and 10 indicates the worst possible pain.
Rate of blood vessels in the Achilles tendonAt baseline and after 3, 6, and 12 monthRate of blood vessels (n) (neovascularization) will be measured with Ultrasound in Doppler mode and compared with the healthy side.
Achilles Tendon cross-sectional areaAt baseline and after 3, 6 and 12 monthsAchilles Tendon cross-sectional area in square centimeters will be evaluated with ultrasound in the midportion of the tendon
Physical Activity Scale (PAS)At baseline and after 3,6 and 12 monthsA patient reported outcome used for the purpose to evaluate the patients self estimated physical activity level. The scale is from 1 to 6 and the higher score, the better outcome.
VISA-ASAt baseline and after 3, 6 and 12 monthsA valid and reliable questionnaire developed for patients with an Achilles Tendinopathy with a purpose to evaluate patient reported outcome in terms of symptoms and function. The values can be between 0 and 100 and the higher score, the better outcome
Heel-rise height during heel-rise work testAt baseline and after 3, 6 and 12 monthsEvaluation of heel-rise height (cm) during heel-rise work test. Comparison between groups in heel-rise height Limb Symmetry Index (LSI) - injured side/healthy side \*100 expressed in percent. The range in LSI is between 0-100% and the higher value, the better outcome
Evaluation of lower leg endurance with heel-rise work (Joule)At baseline and after 3, 6 and 12 monthsEvaluation of lower leg endurance with heel-rise work (Joule) during heel-rise work test. Comparison between groups in heel-rise work Limb Symmetry Index (LSI) - injured side/healthy side \*100 expressed in percent. The range in LSI is between 0-100% and the higher value, the better outcome
Numbers of heel-rises during heel-rise work testAt baseline and after 3, 6 and 12 monthsEvaluation of numbers of heel-rises during heel-rise work test. Comparison between groups in numbers of heel-rises Limb Symmetry Index (LSI) - injured side/healthy side \*100 expressed in percent. The range in LSI is between 0-100% and the higher value, the better outcome
Calf muscle powerAt baseline and after 3, 6 and 12 monthsEvaluation of calf muscle power in a weight training machine expressed in watt (Newton x meter /seconds). Comparison will be performed between groups and limbs in power (LSI)- injured side/healthy side \*100 expressed in percent.The range in LSI is between 0-100% and the higher value, the better outcome
Drop Countermovement JumpAt baseline and after 3, 6 and 12 monthsDrop Countermovement Jump: Evaluation of vertical jumping height after jumping from a 20 cm high box. The outcome will be measured as the height the patient can perform in jump height after landing in cm. Comparison between groups and limbs in jump height will be presented as Limb Symmetry Index (LSI)- injured side/healthy side \*100 expressed in percent. The range in LSI is between 0-100% and the higher value, the better outcome.
HoppingAt baseline and after 3, 6 and 12 monthsEvaluation of series of jumps as in jumping ropes. The outcome measurement will be mean jumping height in cm and elasticity ratio in 20 jumps. Comparison between groups and limbs in jump height and elasticity ratio will be presented as Limb Symmetry Index (LSI)- injured side/healthy side \*100 expressed in percent. The range in LSI is between 0-100% and the higher value, the better outcome
Range of motion in the ankleAt baseline and after 3, 6 and 12 monthsRange of motion in both ankles will be measured with an inclinometer in degrees both with the knee bent and with the knee straight. Comparison between groups and limbs in jump height will be presented as Limb Symmetry Index (LSI)- injured side/healthy side \*100 expressed in percent. The range in LSI is between 0-100% and the higher value, the better outcome.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 7, 2026